These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10172351)

  • 1. Sale of drugs and health care utilization in a health care district in Zaire.
    Courtois X; Dumoulin J
    Health Policy Plan; 1995 Jun; 10(2):181-6. PubMed ID: 10172351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local cost sharing in Bamako Initiative systems in Benin and Guinea: assuring the financial viability of primary health care.
    Soucat A; Levy-Bruhl D; Gbedonou P; Drame K; Lamarque JP; Diallo S; Osseni R; Adovohekpe P; Ortiz C; Debeugny C; Knippenberg R
    Int J Health Plann Manage; 1997 Jun; 12 Suppl 1():S109-35. PubMed ID: 10169906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revolving drug funds at front-line health facilities in Vientiane, Lao PDR.
    Murakami H; Phommasack B; Oula R; Sinxomphou S
    Health Policy Plan; 2001 Mar; 16(1):98-106. PubMed ID: 11238436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multinational drug companies in Zaire: their adverse effect on cost and availability of essential drugs.
    Glucksberg H; Singer J
    Int J Health Serv; 1982; 12(3):381-7. PubMed ID: 7118328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. User charges in government health facilities in Kenya: effect on attendance and revenue.
    Mwabu G; Mwanzia J; Liambila W
    Health Policy Plan; 1995 Jun; 10(2):164-70. PubMed ID: 10143454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing out-of-pocket expenditures for primary health care: how responsive is the Democratic Republic of Congo health system to providing financial risk protection?
    Laokri S; Soelaeman R; Hotchkiss DR
    BMC Health Serv Res; 2018 Jun; 18(1):451. PubMed ID: 29903000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of sustaining the Ghana's "Cash and Carry" system of health care financing at a rural health centre.
    Biritwum RB
    West Afr J Med; 1994; 13(2):124-7. PubMed ID: 7803327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medications and financing of health systems in Third World countries. Cost recovery: a concept to review].
    Velasquez G
    Tiers Monde; 1989; 30(118):455-63. PubMed ID: 12316194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the cost and willingness to pay for voluntary HIV counselling and testing in Kenya.
    Forsythe S; Arthur G; Ngatia G; Mutemi R; Odhiambo J; Gilks C
    Health Policy Plan; 2002 Jun; 17(2):187-95. PubMed ID: 12000779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health care organization and health in a region of Zaire].
    Campanella N; Tarantini F
    Ann Ig; 1989; 1(6):1389-417. PubMed ID: 2484474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary health care, community participation and community-financing: experiences of two middle hill villages in Nepal.
    Sepehri A; Pettigrew J
    Health Policy Plan; 1996 Mar; 11(1):93-100. PubMed ID: 10155881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug utilization at primary health care level in southern India.
    Bapna JS; Tekur U; Gitanjali B; Shashindran CH; Pradhan SC; Thulasimani M; Tomson G
    Eur J Clin Pharmacol; 1992; 43(4):413-5. PubMed ID: 1451722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European healthcare policies for controlling drug expenditure.
    Ess SM; Schneeweiss S; Szucs TD
    Pharmacoeconomics; 2003; 21(2):89-103. PubMed ID: 12515571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving financial access to health care in the Kisantu district in the Democratic Republic of Congo: acting upon complexity.
    Stasse S; Vita D; Kimfuta J; da Silveira VC; Bossyns P; Criel B
    Glob Health Action; 2015; 8():25480. PubMed ID: 25563450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Essential drugs: availability and prescription in Monastir (Tunisia) health district].
    Ben Salem K; Belghith Z; Ben Amor J; Harzallah S; Soltani MS
    East Mediterr Health J; 2000; 6(2-3):326-32. PubMed ID: 11556019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors affecting drug expenditure in the primary care centre in a health area].
    Azpiazu Garrido M; García Olmos L
    Aten Primaria; 2002 Feb; 29(2):84-9. PubMed ID: 11844424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reforms in the Greek pharmaceutical market during the financial crisis.
    Vandoros S; Stargardt T
    Health Policy; 2013 Jan; 109(1):1-6. PubMed ID: 22959163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of free health care for all Kenyans: assessing the financial sustainability of contributory and non-contributory financing mechanisms.
    Okungu V; Chuma J; McIntyre D
    Int J Equity Health; 2017 Feb; 16(1):39. PubMed ID: 28241826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria.
    Uzochukwu BS; Onwujekwe OE; Akpala CO
    Health Policy Plan; 2002 Dec; 17(4):378-83. PubMed ID: 12424209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.